The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!
Anthony Prentice, insider at Sema4

Anthony Prentice Insider Information

Insider of Sema4
Tony Prentice is an innovative product developer, strategist, and leader with extensive experience building and running product, marketing, and partnership organizations. His career spans multiple industries including big data, healthcare, mobile applications, customer experience, financial services, and consumer products.

As Sema4’s Chief Product Officer, Tony is responsible for the strategy and execution of all product-related activities including our patient apps, provider apps, information products for health systems and pharma, clinical software, and new product development of our genomic solutions in Oncology and Women’s Health.

Prior to joining Sema4, Tony served as the Vice President of Mobile Payments at American Express, where he built the organization for new commerce products, applications, and mobile wallets. The team delivered enterprise strategy and products including Apple Pay, Android Pay, and the Amex app.

Previously, Tony held other senior product management roles at American Express for Gold Card, Starwood, Hilton and Blue cards. Before American Express, Tony had various product, general manager, and engineering roles at Starbucks, McKinsey & Company, and General Electric.

What is Anthony Prentice's net worth?

The estimated net worth of Anthony Prentice is at least $21,889.20 as of April 28th, 2022. Mr. Prentice owns 9,860 shares of Sema4 stock worth more than $21,889 as of August 11th. This net worth evaluation does not reflect any other investments that Mr. Prentice may own. Learn More about Anthony Prentice's net worth.

How do I contact Anthony Prentice?

The corporate mailing address for Mr. Prentice and other Sema4 executives is 667 Madison Avenue, New York NY, 10065. Sema4 can also be reached via phone at 800-298-6470 and via email at [email protected] Learn More on Anthony Prentice's contact information.

Has Anthony Prentice been buying or selling shares of Sema4?

Anthony Prentice has not been actively trading shares of Sema4 during the last quarter. Most recently, Anthony Prentice sold 1,691 shares of the business's stock in a transaction on Thursday, April 28th. The shares were sold at an average price of $2.18, for a transaction totalling $3,686.38. Following the completion of the sale, the insider now directly owns 9,860 shares of the company's stock, valued at $21,494.80. Learn More on Anthony Prentice's trading history.

Who are Sema4's active insiders?

Sema4's insider roster includes Shawn Assad (CAO), Daniel Clark (General Counsel), James Coffin (COO), Anthony Prentice (Insider), Isaac Ro (CFO), and Eric Schadt (CEO). Learn More on Sema4's active insiders.

Are insiders buying or selling shares of Sema4?

During the last twelve months, Sema4 insiders bought shares 3 times. They purchased a total of 14,037,500 shares worth more than $55,942,000.00. During the last twelve months, insiders at the sold shares 23 times. They sold a total of 237,572 shares worth more than $1,212,846.46. The most recent insider tranaction occured on August, 9th when CFO Isaac Ro sold 20,245 shares worth more than $40,287.55. Learn More about insider trades at Sema4.

Information on this page was last updated on 8/9/2022.

Anthony Prentice Insider Trading History at Sema4

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2022Sell1,691$2.18$3,686.389,860View SEC Filing Icon  
1/28/2022Sell2,021$2.84$5,739.64View SEC Filing Icon  
10/25/2021Sell1,620$8.09$13,105.80View SEC Filing Icon  
See Full Table

Anthony Prentice Buying and Selling Activity at Sema4

This chart shows Anthony Prentice's buying and selling at Sema4 by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Sema4 Company Overview

Sema4 logo
Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commercialization life-cycle, as well as analytics for actionable insights, pre-clinical and clinical trial support, and advanced sequencing services. It also offers Sema4 Signal that enables and advances precision oncology care, from prevention to treatment to remission; and testing for carrier screening, noninvasive prenatal testing, and newborn screening, as well as hereditary cancer testing. In addition, the company provides COVID-19 testing solutions. Sema4 Holdings Corp. was incorporated in 2020 and is headquartered in Stamford, Connecticut.
Read More

Today's Range

Now: $2.22
Low: $1.89
High: $2.22

50 Day Range

MA: $1.65
Low: $1.22
High: $2.22

2 Week Range

Now: $2.22
Low: $1.11
High: $12.65

Volume

2,033,592 shs

Average Volume

1,874,692 shs

Market Capitalization

$837.49 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.92
The Safest Option in Trades!
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!